Literature DB >> 26159430

Mohs micrographic surgery for periocular skin tumours in Ireland.

M P Treacy1, N C Wynne2, J L Gale1, E Duignan1, B Moran1, A M Flynn1,3, P Ormond1,3, R Barry1,3, R Khan1, P Moriarty1, L Cassidy1.   

Abstract

OBJECTIVE: To describe the shared care and outcomes of patients with periocular skin tumours who underwent Mohs micrographic surgery (MMS) performed by dermatologists, followed by oculoplastic reconstruction undertaken by ophthalmologists at two teaching and one private hospital in Ireland. RESEARCH DESIGN AND METHODS: This was a retrospective chart review at the Royal Victoria Eye and Ear Hospital, St James Hospital and the Hermitage Clinic.
RESULTS: One hundred and twenty seven patients had periocular Mohs surgery between November 2006 and January 2013 mainly indicated for basal cell carcinoma. The mean follow-up time was 2 years and to date there have been no local recurrences.
CONCLUSIONS: MMS is available in Ireland and should be considered for patients with facial tumours in the ocular region.

Entities:  

Keywords:  Mohs micrographic surgery; Periocular BCCs; Periocular reconstruction; Periocular tumours

Mesh:

Year:  2015        PMID: 26159430     DOI: 10.1007/s11845-015-1296-3

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  44 in total

1.  Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.

Authors:  Igal Leibovitch; Shyamala C Huilgol; Dinesh Selva; Shawn Richards; Robert Paver
Journal:  J Am Acad Dermatol       Date:  2005-09       Impact factor: 11.527

Review 2.  Mohs micrographic surgery for facial skin cancer.

Authors:  H D Vuyk; P J Lohuis
Journal:  Clin Otolaryngol Allied Sci       Date:  2001-08

3.  The many faces of basal-cell carcinoma.

Authors:  T R Wade; A B Ackerman
Journal:  J Dermatol Surg Oncol       Date:  1978-01

Review 4.  Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.

Authors:  D E Rowe; R J Carroll; C L Day
Journal:  J Am Acad Dermatol       Date:  1992-06       Impact factor: 11.527

5.  Mohs surgery for periocular basal cell carcinomas.

Authors:  P Robins; R Rodríguez-Sains; H Rabinovitz; D Rigel
Journal:  J Dermatol Surg Oncol       Date:  1985-12

6.  Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.

Authors:  Brigitte A B Essers; Carmen D Dirksen; Fred H M Nieman; Nicole W J Smeets; Gertrude A M Krekels; Martin H Prins; H A Martino Neumann
Journal:  Arch Dermatol       Date:  2006-02

7.  Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.

Authors:  D E Rowe; R J Carroll; C L Day
Journal:  J Dermatol Surg Oncol       Date:  1989-04

Review 8.  Why classify basal cell carcinomas?

Authors:  J J Rippey
Journal:  Histopathology       Date:  1998-05       Impact factor: 5.087

9.  Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.

Authors:  Tracy L Bialy; James Whalen; Emir Veledar; Denis Lafreniere; Jeffrey Spiro; Timothy Chartier; Suephy C Chen
Journal:  Arch Dermatol       Date:  2004-06

Review 10.  Sebaceous carcinoma of the ocular adnexa.

Authors:  L G Kass; A Hornblass
Journal:  Surv Ophthalmol       Date:  1989 May-Jun       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.